USD 3.73
(6.27%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 11.4 Million USD | 653.6% |
2022 | 1.51 Million USD | -79.91% |
2021 | 7.53 Million USD | 179.64% |
2020 | -9.45 Million USD | 40.51% |
2019 | -15.89 Million USD | -13.78% |
2018 | -13.97 Million USD | -243.08% |
2017 | -4.07 Million USD | -138.53% |
2016 | 10.57 Million USD | 19455.31% |
2015 | -54.61 Thousand USD | -104.26% |
2014 | 1.28 Million USD | -58.21% |
2013 | 3.06 Million USD | 131.04% |
2012 | 1.32 Million USD | 162.07% |
2011 | 506.5 Thousand USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | 9.15 Million USD | -19.67% |
2024 Q2 | 6.2 Million USD | -32.24% |
2023 Q2 | 7.06 Million USD | 3.14% |
2023 Q3 | 10.69 Million USD | 51.31% |
2023 FY | 11.4 Million USD | 653.6% |
2023 Q1 | 6.85 Million USD | 352.88% |
2023 Q4 | 11.4 Million USD | 6.63% |
2022 Q2 | 4.35 Million USD | -7.6% |
2022 Q3 | 2.16 Million USD | -50.36% |
2022 Q4 | 1.51 Million USD | -29.95% |
2022 FY | 1.51 Million USD | -79.91% |
2022 Q1 | 4.7 Million USD | -37.48% |
2021 Q3 | 7.25 Million USD | 5.53% |
2021 Q4 | 7.53 Million USD | 3.8% |
2021 Q1 | -11.33 Million USD | -19.88% |
2021 FY | 7.53 Million USD | 179.64% |
2021 Q2 | 6.87 Million USD | 160.65% |
2020 Q4 | -9.45 Million USD | 13.08% |
2020 Q1 | 8.61 Million USD | 154.19% |
2020 FY | -9.45 Million USD | 40.51% |
2020 Q2 | 9.68 Million USD | 12.39% |
2020 Q3 | -10.88 Million USD | -212.36% |
2019 Q1 | -7.97 Million USD | 42.92% |
2019 Q2 | -5.31 Million USD | 33.32% |
2019 FY | -15.89 Million USD | -13.78% |
2019 Q3 | -9.01 Million USD | -69.59% |
2019 Q4 | -15.89 Million USD | -76.27% |
2018 Q1 | -3.34 Million USD | 17.88% |
2018 Q2 | -11.5 Million USD | -243.87% |
2018 Q4 | -13.97 Million USD | -2156.45% |
2018 Q3 | -619.21 Thousand USD | 94.62% |
2018 FY | -13.97 Million USD | -243.08% |
2017 FY | -4.07 Million USD | -138.53% |
2017 Q4 | -4.07 Million USD | -905.02% |
2017 Q3 | -405.22 Thousand USD | -109.94% |
2017 Q2 | 4.07 Million USD | -66.29% |
2017 Q1 | 12.08 Million USD | 14.36% |
2016 Q4 | 10.57 Million USD | 285.37% |
2016 FY | 10.57 Million USD | 19455.31% |
2016 Q3 | 2.74 Million USD | -11.97% |
2016 Q2 | 3.11 Million USD | 28.69% |
2016 Q1 | 2.42 Million USD | 4533.62% |
2015 Q3 | 4.13 Million USD | 36.51% |
2015 FY | -54.61 Thousand USD | -104.26% |
2015 Q4 | -54.61 Thousand USD | -101.32% |
2015 Q2 | 3.03 Million USD | 13.4% |
2015 Q1 | 2.67 Million USD | 108.66% |
2014 Q3 | 44.77 Thousand USD | -98.6% |
2014 Q1 | 3.16 Million USD | 3.22% |
2014 FY | 1.28 Million USD | -58.21% |
2014 Q2 | 3.19 Million USD | 0.86% |
2014 Q4 | 1.28 Million USD | 2762.2% |
2013 Q3 | 3.34 Million USD | 0.0% |
2013 FY | 3.06 Million USD | 131.04% |
2013 Q1 | 268.32 Thousand USD | -79.79% |
2013 Q4 | 3.06 Million USD | -8.23% |
2012 FY | 1.32 Million USD | 162.07% |
2012 Q4 | 1.32 Million USD | 0.0% |
2011 FY | 506.5 Thousand USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Inovalon Holdings, Inc. | 773.42 Million USD | 98.526% |
GE HealthCare Technologies Inc. | 7.36 Billion USD | 99.845% |
Sharecare, Inc. | -125.84 Million USD | 109.061% |
Progyny, Inc. | -77.9 Million USD | 114.636% |
Aclarion, Inc. | 94.65 Thousand USD | -11945.851% |
CareMax, Inc. | 426.4 Million USD | 97.326% |
Simulations Plus, Inc. | -9.83 Million USD | 215.921% |
Forian Inc. | 16.95 Million USD | 32.766% |
Bullfrog AI Holdings, Inc. Warrants | -2.62 Million USD | 534.407% |
Bullfrog AI Holdings, Inc. Common Stock | -2.62 Million USD | 534.407% |
Minerva Surgical, Inc. | 32.74 Million USD | 65.183% |
Omnicell, Inc. | 113.11 Million USD | 89.92% |
Definitive Healthcare Corp. | 136.95 Million USD | 91.674% |
Zhongchao Inc. | -6.74 Million USD | 269.156% |
Accolade, Inc. | 55.93 Million USD | 79.614% |
Streamline Health Solutions, Inc. | 7.37 Million USD | -54.582% |
Ontrak, Inc. | -8.01 Million USD | 242.312% |
SOPHiA GENETICS SA | -104.65 Million USD | 110.895% |
R1 RCM Inc. | 1.56 Billion USD | 99.272% |
Spok Holdings, Inc. | -20.9 Million USD | 154.547% |
Privia Health Group, Inc. | -381.22 Million USD | 102.991% |
EUDA Health Holdings Limited | 3.18 Million USD | -257.932% |
HeartBeam, Inc. | -16.18 Million USD | 170.431% |
GeneDx Holdings Corp. | 20.08 Million USD | 43.243% |
TruBridge, Inc. | 199.44 Million USD | 94.283% |
Nutex Health, Inc. | 253.75 Million USD | 95.507% |
Renalytix Plc | 3.85 Million USD | -195.772% |
Sharecare, Inc. | -125.84 Million USD | 109.061% |
Health Catalyst, Inc. | 142.79 Million USD | 92.015% |
10x Genomics, Inc. | -263.91 Million USD | 104.32% |
GoodRx Holdings, Inc. | 38.77 Million USD | 70.594% |
SCWorx Corp. | -1077.00 USD | 1058781.523% |
Schrödinger, Inc. | -33.18 Million USD | 134.36% |
HealthEquity, Inc. | 529.16 Million USD | 97.845% |
HealthStream, Inc. | -17.11 Million USD | 166.632% |
MSP Recovery, Inc. | 667.69 Million USD | 98.292% |
Augmedix, Inc. | -20.49 Million USD | 155.63% |
BrightSpring Health Services, Inc. Common Stock | 3.65 Billion USD | 99.688% |
Ontrak, Inc. | -8.01 Million USD | 242.312% |
SHL Telemedicine Ltd. | 13.15 Million USD | 13.346% |
CareCloud, Inc. | 11.4 Million USD | 0.0% |
Premier, Inc. | 855 Thousand USD | -1233.567% |
Certara, Inc. | 63.24 Million USD | 81.971% |
GeneDx Holdings Corp. | 20.08 Million USD | 43.243% |
OneMedNet Corporation | 5.05 Million USD | -125.59% |
BrightSpring Health Services, Inc. Tangible Equity Unit | 3.65 Billion USD | 99.688% |
EUDA Health Holdings Limited | 3.18 Million USD | -257.932% |
HeartBeam, Inc. | -16.18 Million USD | 170.431% |
CareCloud, Inc. | 11.4 Million USD | 0.0% |
Mangoceuticals, Inc. | -610.32 Thousand USD | 1968.176% |
CareMax, Inc. | 426.4 Million USD | 97.326% |
Healthcare Triangle, Inc. | 3.08 Million USD | -269.835% |
National Research Corporation | 32.3 Million USD | 64.703% |
Aclarion, Inc. | 94.65 Thousand USD | -11945.851% |
OptimizeRx Corporation | 22.97 Million USD | 50.364% |